NASDAQ: CYCNCyclerion Therapeutics Inc Stock Ownership - Who owns Cyclerion Therapeutics?
Insider buying vs selling
Have Cyclerion Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter M. Hecht | Director | 2025-03-25 | 181,818 | $2.75 | $500.00kBuy |
| Michael J. 1. Higgins | Director | 2025-03-25 | 9,090 | $2.75 | $25.00kBuy |
| Slate Path Capital LP | 10% Owner | 2024-11-21 | 357,880 | $1.55 | $555.07kSell |
CYCN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CYCN insiders and whales buy or sell their stock.
CYCN Shareholders
What type of owners hold Cyclerion Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Terrance McGuire | 23.11% | 771,191 | $1.44M | Insider |
| Amy W. Schulman | 18.99% | 633,625 | $1.18M | Insider |
| Peter M. Hecht | 16.77% | 559,760 | $1.05M | Insider |
| Andreas Busch | 7.63% | 254,704 | $476.30k | Insider |
| Mark G. Currie | 7.54% | 251,648 | $470.58k | Insider |
| Tyndall Capital Partners L P | 4.65% | 155,187 | $290.20k | Institution |
| Siren LLC | 3.48% | 116,155 | $217.21k | Institution |
| Regina Margaret Graul | 3.01% | 100,303 | $187.57k | Insider |
| William Huyett | 2.03% | 67,590 | $126.39k | Insider |
| Christopher I. Wright | 1.28% | 42,728 | $79.90k | Insider |
CYCN vs Biotech Stocks
Cyclerion Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.